GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Microbix Biosystems Inc (OTCPK:MBXBF) » Definitions » Forward PE Ratio

Microbix Biosystems (Microbix Biosystems) Forward PE Ratio : 17.01 (As of Jun. 11, 2024)


View and export this data going back to . Start your Free Trial

What is Microbix Biosystems Forward PE Ratio?

Microbix Biosystems's Forward PE Ratio for today is 17.01.

Microbix Biosystems's PE Ratio without NRI for today is 11.75.

Microbix Biosystems's PE Ratio for today is 11.75.


Microbix Biosystems Forward PE Ratio Historical Data

The historical data trend for Microbix Biosystems's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microbix Biosystems Forward PE Ratio Chart

Microbix Biosystems Annual Data
Trend 2020-12 2021-12 2022-12 2023-12 2024-06
Forward PE Ratio
28.25 21.01 16.18 12.52 17.09

Microbix Biosystems Quarterly Data
2020-06 2020-09 2020-12 2021-03 2021-06 2021-09 2021-12 2022-03 2022-06 2022-09 2022-12 2023-03 2023-06 2023-09 2023-12 2024-03 2024-06
Forward PE Ratio 33.33 31.65 28.25 21.60 7.32 12.79 21.01 13.89 11.55 11.30 16.18 37.45 7.81 10.38 12.52 18.98 17.09

Competitive Comparison of Microbix Biosystems's Forward PE Ratio

For the Biotechnology subindustry, Microbix Biosystems's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Microbix Biosystems's Forward PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Microbix Biosystems's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Microbix Biosystems's Forward PE Ratio falls into.



Microbix Biosystems Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Microbix Biosystems  (OTCPK:MBXBF) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Microbix Biosystems Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Microbix Biosystems's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Microbix Biosystems (Microbix Biosystems) Business Description

Traded in Other Exchanges
Address
265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3
Microbix Biosystems Inc develops biological products and technologies. The company manufactures and develops cell culture-based biological products and technologies. It has developed and acquired two technologies; Kinlytic and LumiSort. The company's operating segment includes Antigen, QAPs DxTM and Other Includes Kinlytic. It generates maximum revenue from the Antigen QAPs segment. Geographically, it derives a majority of revenue from North America.

Microbix Biosystems (Microbix Biosystems) Headlines

From GuruFocus

Microbix Attains Health Canada Establishment Licensing

By GlobeNewswire GlobeNewswire 04-21-2020

Microbix Announces Annual and Special Meeting Voting Results

By GlobeNewswire GlobeNewswire 04-01-2020

Microbix Announces Extension of Warrant Expiry Date

By GlobeNewswire GlobeNewswire 05-18-2023